Shared Beta-Lactam Facilities: Achieving
Recent USFDA warning letter, issued to Baxter (October 2026), citing inadequate beta lactam contamination controls
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
